Results 291 to 300 of about 62,912 (312)

Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series

Ocular immunology and inflammation
Purpose This study analyzes the efficacy and safety of tofacitinib in pediatric patients presenting with treatment-resistant uveitis and scleritis. Method Retrospective Chart Review Result Nine children diagnosed with uveitis and one with scleritis ...
Parthopratim Dutta Majumder, Sharanya Abraham, S. Sudharshan, Mahesh Janarthanan, A. Ramanan   +4 more
semanticscholar   +1 more source

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Lancet, The, 2021
Nicolino Ruperto, Hermine I Brunner, Sampath Prahalad   +2 more
exaly  

Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure

Archives of Dermatological Research
A. Ehsani, Zahra Razavi, Amirhossein Rahimnia, A. Ehsani, Fatemeh Saberi, Zeinab Aryanian, Hanie Babaie   +6 more
semanticscholar   +1 more source

Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis

Clinical Rheumatology, 2023
Yanhua Wang, Jing Luo, Xiaohong Lv, Yuanyuan Li, Qi An, Lingfei Mo, N. Hu, Jing Zhang, Jing Wang, Juan Tian, D. Pu, Zhiming Hao, Lan He   +12 more
semanticscholar   +1 more source

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Lancet, The, 2013
Gerd R Burmester, Ricardo Blanco, Gene Wallenstein   +2 more
exaly  

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Lancet, The, 2017
Roy M Fleischmann, Robert J Moots, Liza Takiya   +2 more
exaly  

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

Lancet, The, 2015
Hervé Bachelez, Peter C M Van De Kerkhof, Alexey Kubanov   +2 more
exaly  

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

Gut, 2017
Bruce E Sands, Séverine Vermeire, Geert D'Haens   +2 more
exaly  

Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

Arthritis and Rheumatism, 2013
Désirée M Van Der Heijde, Yoshiya Tanaka, Roy M Fleischmann   +2 more
exaly  

The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway

Archives of Dermatological Research
Rui Sun, Huiping Fan, Jiayun Liu, Guomin Gao, Chengqi Liu, Dong Zhang, Weiyuan Ma   +6 more
semanticscholar   +1 more source